Financial Performance - The company's operating revenue for 2023 is expected to be ¥1,136,261,735.60, a decrease of 42.69% compared to the previous year[6] - The net profit attributable to shareholders is projected to be ¥15,134,700.57, down 77.74% year-on-year[6] - The net profit attributable to shareholders after deducting non-recurring gains and losses is expected to be ¥11,239,030.47, a decline of 83.42% compared to the previous year[6] - Basic earnings per share decreased by 80.00% due to the decline in net profit and an increase in share capital[9] Assets and Equity - Total assets at the end of the reporting period are estimated to be ¥999,348,133.29, an increase of 33.56% year-on-year[6] - The equity attributable to shareholders is projected to be ¥638,392,667.96, up 13.41% from the previous year[6] Revenue Drivers - The company experienced a significant decline in revenue primarily due to a sharp drop in precious metal raw material prices, with rhodium prices falling from approximately ¥3.1 million per kg to ¥1.1 million per kg[7] - The sales volume of precious metal precursor products increased by 47.79% year-on-year, while the sales volume of precious metal catalysts and processing business rose by 19.94%[7] Research and Development - Research and development expenses for 2023 are expected to be ¥10,033,300, reflecting a 73.84% increase year-on-year[9] - The company continues to invest in R&D to enhance product competitiveness and maintain its leading position in the industry despite external challenges[9]
凯大催化(830974) - 2023 Q4 - 年度业绩